Kronos Bio (KRON) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.
No Form 4 insider filings for KRON were recorded at the SEC in the past 30 days[1].
Sources
- SEC EDGAR (2026-04-11) ↗
KRON is tracked by BiotechSigns with a current catalyst score of 53/100 and grade C. The page summarizes 0 active signals, including 0 PDUFA, 0 insider buying, and 0 clinical trial signals, with data refreshed on 2026-06-04.
Kronos Bio (KRON) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.
No Form 4 insider filings for KRON were recorded at the SEC in the past 30 days[1].